BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34066878)

  • 1. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
    Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
    Molecules; 2021 May; 26(9):. PubMed ID: 34066878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
    Saentaweesuk W; Silsirivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Pairojkul C; Cha'on U; Indramanee S; Pinlaor S; Boonmars T; Araki N; Wongkham C
    Clin Chim Acta; 2018 Feb; 477():66-71. PubMed ID: 29217428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
    Phuyathip W; Putthisen S; Panawan O; Ma-In P; Teeravirote K; Sintusen P; Udomkitkosol S; Detarya M; Luang S; Mahalapbutr P; Sato T; Kuno A; Chuangchaiya S; Silsirivanit A
    Histochem Cell Biol; 2024 May; 161(5):423-434. PubMed ID: 38393396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
    Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
    Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
    Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
    Rucksaken R; Charoensuk L; Pinlaor P; Pairojkul C; Khuntikeo N; Pinlaor S
    Cancer Biomark; 2017; 18(1):27-34. PubMed ID: 27814272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
    Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
    Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.
    Kimawaha P; Thanan R; Jusakul A; Jamnongkan W; Silsirivanit A; Sa-Ngaimwibool P; Titapun A; Khuntikeo N; Sithithaworn P; Worasith C; Janthamala S; Lebrilla CB; Techasen A
    Clin Chim Acta; 2022 Nov; 536():142-154. PubMed ID: 36174722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Biomarkers for Cholangiocarcinoma.
    Loosen SH; Vucur M; Trautwein C; Roderburg C; Luedde T
    Dig Dis; 2018; 36(4):281-288. PubMed ID: 29807369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring.
    Wen N; Peng D; Xiong X; Liu G; Nie G; Wang Y; Xu J; Wang S; Yang S; Tian Y; Li B; Lu J; Cheng N
    Signal Transduct Target Ther; 2024 May; 9(1):107. PubMed ID: 38697972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
    Rucksaken R; Pairojkul C; Pinlaor P; Khuntikeo N; Roytrakul S; Selmi C; Pinlaor S
    PLoS One; 2014; 9(7):e103259. PubMed ID: 25058392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum N-glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma.
    Wang M; Fang M; Zhu J; Feng H; Warner E; Yi C; Ji J; Gu X; Gao C
    Electrophoresis; 2017 Nov; 38(21):2749-2756. PubMed ID: 28752594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.